Shogo Takeuchi

545 total citations
20 papers, 343 citations indexed

About

Shogo Takeuchi is a scholar working on Immunology, Ecology, Evolution, Behavior and Systematics and Dermatology. According to data from OpenAlex, Shogo Takeuchi has authored 20 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 13 papers in Ecology, Evolution, Behavior and Systematics and 5 papers in Dermatology. Recurrent topics in Shogo Takeuchi's work include T-cell and Retrovirus Studies (16 papers), Vector-Borne Animal Diseases (13 papers) and Cutaneous lymphoproliferative disorders research (5 papers). Shogo Takeuchi is often cited by papers focused on T-cell and Retrovirus Studies (16 papers), Vector-Borne Animal Diseases (13 papers) and Cutaneous lymphoproliferative disorders research (5 papers). Shogo Takeuchi collaborates with scholars based in Japan and United States. Shogo Takeuchi's co-authors include Y Takatsuka, Atae Utsunomiya, Takashi Ishida, Kentaro Yonekura, Nobuaki Nakano, Ryuzo Ueda, Masahito Tokunaga, Ayumu Kubota, Shinsuke Iida and Hirokazu Komatsu and has published in prestigious journals such as Blood, International Journal of Cancer and Journal Of Clinical Periodontology.

In The Last Decade

Shogo Takeuchi

19 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shogo Takeuchi Japan 11 189 91 87 67 51 20 343
Masahito Tokunaga Japan 11 269 1.4× 89 1.0× 157 1.8× 157 2.3× 34 0.7× 38 424
Yoshitaka Inoue Japan 13 310 1.6× 89 1.0× 182 2.1× 131 2.0× 76 1.5× 38 514
Masaharu Miyahara Japan 11 173 0.9× 64 0.7× 86 1.0× 62 0.9× 79 1.5× 32 321
Gill Ps United States 9 180 1.0× 101 1.1× 87 1.0× 85 1.3× 88 1.7× 17 342
Satoko Oka Japan 10 98 0.5× 69 0.8× 40 0.5× 32 0.5× 47 0.9× 59 297
K Uozumi Japan 5 394 2.1× 131 1.4× 267 3.1× 217 3.2× 42 0.8× 16 501
Toshimasa Kukita Japan 11 203 1.1× 47 0.5× 110 1.3× 90 1.3× 24 0.5× 29 335
G. Rossi Italy 8 148 0.8× 99 1.1× 20 0.2× 23 0.3× 113 2.2× 17 337
Kentaro Yonekura Japan 12 265 1.4× 57 0.6× 116 1.3× 87 1.3× 105 2.1× 29 394
Abbas Shirdel Iran 12 337 1.8× 43 0.5× 197 2.3× 209 3.1× 37 0.7× 34 516

Countries citing papers authored by Shogo Takeuchi

Since Specialization
Citations

This map shows the geographic impact of Shogo Takeuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shogo Takeuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shogo Takeuchi more than expected).

Fields of papers citing papers by Shogo Takeuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shogo Takeuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shogo Takeuchi. The network helps show where Shogo Takeuchi may publish in the future.

Co-authorship network of co-authors of Shogo Takeuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Shogo Takeuchi. A scholar is included among the top collaborators of Shogo Takeuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shogo Takeuchi. Shogo Takeuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakano, Nobuaki, Y Takatsuka, Ayumu Kubota, et al.. (2021). Cord blood transplantation with a reduced-intensity conditioning regimen using fludarabine and melphalan for adult T-cell leukemia/lymphoma. International Journal of Hematology. 113(6). 861–871. 2 indexed citations
2.
Ogawa, Miho, Sayaka Katagiri, Tatsuro Koyanagi, et al.. (2020). Accuracy of cone beam computed tomography in evaluation of palatal mucosa thickness. Journal Of Clinical Periodontology. 47(4). 479–488. 14 indexed citations
3.
Takeuchi, Shogo, et al.. (2017). 18F-FDG PET/CT Imaging of Epididymal Smooth Muscle Mass Mimicking Recurrent Lymphoma. Clinical Nuclear Medicine. 42(4). e224–e226. 2 indexed citations
4.
Tokunaga, Masahito, Hirofumi Uto, Shogo Takeuchi, et al.. (2016). Newly identified poor prognostic factors for adult T-cell leukemia–lymphoma treated with allogeneic hematopoietic stem cell transplantation. Leukemia & lymphoma. 58(1). 37–44. 9 indexed citations
5.
Tokunaga, Masahito, Noriaki Yoshida, Nobuaki Nakano, et al.. (2016). Detection of an early adult T-cell leukemia-lymphoma clone in lymph nodes with anaplastic lymphoma kinase-negative anaplastic large cell lymphoma involvement. Cancer Genetics. 209(4). 138–142.
6.
Yonekura, Kentaro, Masahito Tokunaga, Tamotsu Kanzaki, et al.. (2016). Cutaneous Adverse Reaction to Mogamulizumab May Indicate Favourable Prognosis in Adult T-cell Leukaemia-lymphoma. Acta Dermato Venereologica. 96(7). 1000–1002. 10 indexed citations
7.
Yonekura, Kentaro, Atae Utsunomiya, Masao Seto, et al.. (2015). Human T‐lymphotropic virus type I proviral loads in patients with adult T‐cell leukemia–lymphoma: Comparison between cutaneous type and other subtypes. The Journal of Dermatology. 42(12). 1143–1148. 7 indexed citations
8.
Ishitsuka, Kenji, Atae Utsunomiya, Hiroo Katsuya, et al.. (2015). A phase II study of bortezomib in patients with relapsed or refractory aggressive adult T‐cell leukemia/lymphoma. Cancer Science. 106(9). 1219–1223. 28 indexed citations
9.
Dozono, Koichiro, Nobuaki Nakano, Ayumu Kubota, et al.. (2014). Effect of exercise therapy on muscle mass and physical functioning in patients undergoing allogeneic hematopoietic stem cell transplantation. Supportive Care in Cancer. 23(4). 985–992. 51 indexed citations
10.
Takahashi, Yuka, Katsuyoshi Takata, Seiichi Kato, et al.. (2014). Clinicopathological analysis of 17 primary cutaneous T‐cell lymphoma of the γδ phenotype from Japan. Cancer Science. 105(7). 912–923. 18 indexed citations
11.
Yonekura, Kentaro, Tamotsu Kanzaki, Nobuaki Nakano, et al.. (2014). Effect of a novel anti-CCR4 monoclonal antibody (Mogamulizmab) on skin lesions of adult T-cell leukemia-lymphoma (ATL) and its adverse skin reactions (ASR). Retrovirology. 11(S1). 1 indexed citations
12.
Yonekura, Kentaro, Tamotsu Kanzaki, Y Takatsuka, et al.. (2014). Effect of anti‐CCR4 monoclonal antibody (mogamulizumab) on adult T‐cell leukemia–lymphoma: Cutaneous adverse reactions may predict the prognosis. The Journal of Dermatology. 41(3). 239–244. 40 indexed citations
13.
Nakano, Nobuaki, Shigeru Kusumoto, Yasuhito Tanaka, et al.. (2013). Reactivation of hepatitis B virus in a patient with adult T‐cell leukemia–lymphoma receiving the anti‐CC chemokine receptor 4 antibody mogamulizumab. Hepatology Research. 44(3). 354–357. 25 indexed citations
14.
Inagaki, Atsushi, Takashi Ishida, Hiroki Yano, et al.. (2008). Clinical Significance of Serum TARC/CCL17 in ATLL Patients: High TARC/CCL17 Level Is a Significant Unfavorable Prognostic Factor. Blood. 112(11). 2821–2821. 2 indexed citations
15.
Utsunomiya, Atae, Takashi Ishida, Atsushi Inagaki, et al.. (2006). Clinical significance of a blood eosinophilia in adult T-cell leukemia/lymphoma: A blood eosinophilia is a significant unfavorable prognostic factor. Leukemia Research. 31(7). 915–920. 42 indexed citations
16.
Inagaki, Atsushi, Takashi Ishida, Toshihiko Ishii, et al.. (2006). Clinical significance of serum Th1‐, Th2‐ and regulatory T cells‐associated cytokines in adult T‐cell leukemia/lymphoma: High interleukin‐5 and ‐10 levels are significant unfavorable prognostic factors. International Journal of Cancer. 118(12). 3054–3061. 58 indexed citations
17.
Lin, Xiaoyan, Shuichi Hanada, Kimiharu Uozumi, et al.. (2002). Serum Levels of Endogenous Thrombopoietin and Granulocyte-Colony Stimulating Factor in Patients with Acute or Lymphoma Type Adult T-cell Leukemia During Multicycle Chemotherapy. Leukemia & lymphoma. 43(2). 343–349. 3 indexed citations
18.
Kreitman, Robert J., Takeshi Saito, Kimiharu Uozumi, et al.. (2002). Augmentation of the Activity of an Immunotoxin, Anti-Tac(Fv)-PE40KDEL, in T Cell Lines Infected with Human T Cell Leukemia Virus Type-I. Leukemia & lymphoma. 43(4). 885–888. 10 indexed citations
19.
Ishitsuka, Kenji, Ryuji Ikeda, Atae Utsunomiya, et al.. (2002). Arsenic Trioxide Induces Apoptosis in HTLV-I Infected T-cell Lines and Fresh Adult T-cell Leukemia Cells Through CD95 or Tumor Necrosis Factor α Receptor Independent Caspase Activation. Leukemia & lymphoma. 43(5). 1107–1114. 18 indexed citations
20.
Kawabata, Hisashi, Atae Utsunomiya, Shuichi Hanada, et al.. (1999). Myelodysplastic syndrome in a patient with adult T‐cell leukaemia. British Journal of Haematology. 106(3). 702–705. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026